Randomized comparative study of ipragliflozin combination therapy and sitagliptin combination therapy in patients with type 2 diabetes administrating metformin
Phase of Trial: Phase II/III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Ipragliflozin (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 06 Jun 2016 Planned number of patients changed from 220 to 166.
- 06 Jun 2016 Status changed from not yet recruiting to recruiting.
- 22 Jul 2015 New trial record